Mpox Virus: Symptoms, Spread, Treatment, and News: Publications and Documents
Summary
The Disabled World Mpox database contains a diverse collection of publications related to the Mpox virus. These publications include reports, findings, announcements, awareness articles, informative pieces, surveys, and analyses. The database covers a wide range of topics, from recent threats and mutations to public awareness, vaccine information, and outbreak updates. This comprehensive database serves as a valuable resource for those seeking current and authoritative information on the Mpox virus and its global impact.Searching the Database
The data table below lists items that may have been updated or revised, but the table defaults to sorting by descending publication date; you can search and sort by clicking column headers (JavaScript required). Items in this category are also distributed via our Mpox Virus: Symptoms, Spread, Treatment, and News RSS feed.
| Title and Description | Ed | Publish Revised |
|---|---|---|
| Mpox Knowledge Plummets as New Deadly Strain Emerges Mpox clades I and II are fueling a resurgence, with declining awareness heightening risks; vaccination and education remain key to curbing spread. | ✓ ✓ | |
| Mpox Mutations Evading Vaccines and Spreading Faster Peer-reviewed study reveals mpox virus mutations enhancing spread and resistance to drugs and vaccines, urging development of targeted therapies. | ✓ ✓ | |
| Arteriviridae Monkey Virus on Verge of Infecting Humans Simian arteriviruses in African primates show potential to infect humans, per University of Colorado research, calling for surveillance to prevent spillover pandemics. | ✓ ✓ | |
| Mpox Research Reveals Zoonotic Disease Prevention Needs Peer-reviewed research examines mpox outbreak implications and zoonotic disease prevention strategies for vulnerable populations. | ✓ ✓ | |
| Mpox: Risks, Awareness, and Vaccine Realities Peer-reviewed survey reveals American public knowledge gaps and concerns about mpox transmission, vaccines, and misinformation during the outbreak. | ✓ ✓ | |
| New Drug Strategy Targets Mpox at Molecular Level Scientists use cryo-electron microscopy to develop new mpox treatments by targeting viral transcription machinery at the molecular level. | ✓ ✓ | |
| FDA Update on U.S. Mpox Outbreak FDA details its multipronged response to the U.S. mpox outbreak, including expanded diagnostics, JYNNEOS vaccine approvals, and TPOXX access for treatment. | ✓ ✓ | |
| 1 In 5 Americans Fear Getting Mpox Peer-reviewed study reveals 1 in 5 Americans fear mpox infection, yet most lack basic knowledge about transmission, vaccines, and prevention measures. | ✓ ✓ | |
| WHO Declares Mpox Global Emergency Amid Surge WHO declares mpox a global health emergency, establishing guidelines for healthcare systems to protect vulnerable populations and prevent spread. | ✓ ✓ | |
| Mpox Incubation Period Varies Depending on Type of Exposure Study reveals mpox incubation periods vary by transmission route: 8.5 days for invasive contact, 13 days for droplet exposure. 21-day quarantine captures 98% cases. | ✓ ✓ |
Key: the first check mark indicates the publication carries an editor's note; the second indicates a footnote.
Note: Disabled World compiles disability-related publications as a resource. Inclusion does not imply endorsement by Disabled-World.com. To submit disability-related articles and peer-reviewed manuscripts and papers, ensure submissions comply with our guidelines. For questions, please contact us.
Back to Mpox Virus: Symptoms, Spread, Treatment, and News Index.